These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 23097252)

  • 1. High performance of a new PCR-based urine assay for HPV-DNA detection and genotyping.
    Tanzi E; Bianchi S; Fasolo MM; Frati ER; Mazza F; Martinelli M; Colzani D; Beretta R; Zappa A; Orlando G
    J Med Virol; 2013 Jan; 85(1):91-8. PubMed ID: 23097252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of urine and cervical samples for detecting human papillomavirus (HPV) with the Cobas 4800 HPV test.
    Bernal S; Palomares JC; Artura A; Parra M; Cabezas JL; Robles A; Martín Mazuelos E
    J Clin Virol; 2014 Dec; 61(4):548-52. PubMed ID: 25453566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR.
    Lin CY; Chao A; Yang YC; Chou HH; Ho CM; Lin RW; Chang TC; Chiou JY; Chao FY; Wang KL; Chien TY; Hsueh S; Huang CC; Chen CJ; Lai CH
    J Clin Virol; 2008 Aug; 42(4):361-7. PubMed ID: 18455959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
    Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
    J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real-time PCR systems.
    Payan C; Ducancelle A; Aboubaker MH; Caer J; Tapia M; Chauvin A; Peyronnet D; Le Hen E; Arab Z; Legrand MC; Tran A; Postec E; Tourmen F; Avenel M; Malbois C; De Brux MA; Descamps P; Lunel F
    J Clin Microbiol; 2007 Mar; 45(3):897-901. PubMed ID: 17229868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening.
    Burroni E; Bonanni P; Sani C; Lastrucci V; Carozzi F; ; Iossa A; Andersson KL; Brandigi L; Di Pierro C; Confortini M; Levi M; Boccalini S; Indiani L; Sala A; Tanini T; Bechini A; Azzari C
    J Med Virol; 2015 Mar; 87(3):508-15. PubMed ID: 25418873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of human papillomavirus in urine and cervical swabs from patients with invasive cervical cancer.
    Stanczuk GA; Kay P; Allan B; Chirara M; Tswana SA; Bergstrom S; Sibanda EN; Williamson AL
    J Med Virol; 2003 Sep; 71(1):110-4. PubMed ID: 12858416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the PapilloCheck DNA micro-array Human Papillomavirus detection assay with Hybrid Capture II and PCR-enzyme immunoassay using the GP5/6+ primer set.
    Jones J; Powell NG; Tristram A; Fiander AN; Hibbitts S
    J Clin Virol; 2009 Jun; 45(2):100-4. PubMed ID: 19394266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.
    Broccolo F; Fusetti L; Rosini S; Caraceni D; Zappacosta R; Ciccocioppo L; Matteoli B; Halfon P; Malnati MS; Ceccherini-Nelli L
    J Med Virol; 2013 Mar; 85(3):472-82. PubMed ID: 23280876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
    Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
    J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of AMPLICOR HPV PCR and Linear Array assays on SurePath liquid-based Pap samples for the detection of high-risk HPV genotypes.
    Chernesky M; Jang D; Portillo E; Smieja M; Chong S; Buracond S; Klingel M; El Sebai R; Kapala J; Patel J; Biers K; Harroun N; Doucette C; Sumner J
    J Clin Virol; 2011 Mar; 50(3):201-4. PubMed ID: 21195020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical performance of Invader technology and SurePath when detecting the presence of high-risk HPV cervical infection.
    Harvey M; Stout S; Starkey CR; Hendren R; Holt S; Miller GC
    J Clin Virol; 2009 Jul; 45 Suppl 1():S79-83. PubMed ID: 19651373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and typing of low-risk human papillomavirus genotypes HPV 6, HPV 11, HPV 42, HPV 43 and HPV 44 by polymerase chain reaction and restriction fragment length polymorphism.
    Maver PJ; Poljak M; Seme K; Kocjan BJ
    J Virol Methods; 2010 Oct; 169(1):215-8. PubMed ID: 20637805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative review of laboratory-developed tests utilizing Invader HPV analyte-specific reagents for the detection of high-risk human papillomavirus.
    Stillman MJ; Day SP; Schutzbank TE
    J Clin Virol; 2009 Jul; 45 Suppl 1():S73-7. PubMed ID: 19651372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus oncogene mRNA testing for the detection of anal dysplasia in HIV-positive men who have sex with men.
    Silling S; Kreuter A; Hellmich M; Swoboda J; Pfister H; Wieland U
    J Clin Virol; 2012 Apr; 53(4):325-31. PubMed ID: 22261122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus typing with GP5+/6+ polymerase chain reaction reverse line blotting and with commercial type-specific PCR kits.
    Gillio-Tos A; De Marco L; Ghisetti V; Snijders PJ; Segnan N; Ronco G; Merletti F
    J Clin Virol; 2006 Jun; 36(2):126-32. PubMed ID: 16624614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction.
    Gravitt PE; Lacey JV; Brinton LA; Barnes WA; Kornegay JR; Greenberg MD; Greene SM; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Zaino R; Hildesheim A
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):95-100. PubMed ID: 11219778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the f-HPV typing™ and Hybrid Capture II® assays for detection of high-risk HPV genotypes in cervical samples.
    Cañadas MP; Cirigliano V; Darwich L; Sirera G; Coll J; Clotet B; Videla S
    J Virol Methods; 2012 Jul; 183(1):14-8. PubMed ID: 22449759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic performance of classical molecular tests used for detecting human papillomavirus.
    Munoz M; Camargo M; Soto-De Leon SC; Rojas-Villarraga A; Sanchez R; Jaimes C; Perez-Prados A; Patarroyo ME; Patarroyo MA
    J Virol Methods; 2012 Oct; 185(1):32-8. PubMed ID: 22659023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.